LAVA Therapeutics NV
CIK 1840748 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for LAVA Therapeutics NV.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Dec 16, 2025 | 15-12G | 0001104659-25-121581 |
| Nov 21, 2025 | SC TO-T/A | 0001193125-25-290606 |
| Nov 21, 2025 | SC 14D9/A | 0001104659-25-114795 |
| Nov 21, 2025 | S-8 POS | 0001104659-25-114799 |
| Nov 21, 2025 | S-8 POS | 0001104659-25-114797 |
| Nov 21, 2025 | 8-K | 0001104659-25-114793 |
| Nov 21, 2025 | 25-NSE/A | 0001354457-25-001168 |
| Nov 17, 2025 | 4 | 0001388000-25-000005 |
| Nov 17, 2025 | 4 | 0001267490-25-000006 |
| Nov 17, 2025 | 4 | 0001796398-25-000004 |
| Nov 17, 2025 | 4 | 0001328146-25-000004 |
| Nov 17, 2025 | 4 | 0001331339-25-000005 |
| Nov 17, 2025 | 4 | 0001814695-25-000005 |
| Nov 17, 2025 | 4 | 0001130637-25-000005 |
| Nov 17, 2025 | 4 | 0001822092-25-000005 |
| Nov 17, 2025 | 4 | 0001456849-25-000005 |
| Nov 13, 2025 | 8-K | 0001104659-25-110913 |
| Nov 13, 2025 | SC 14D9/A | 0001104659-25-110947 |
| Nov 13, 2025 | SC TO-T/A | 0001193125-25-278820 |
| Nov 6, 2025 | 10-Q | 0001104659-25-107725 |
| Oct 22, 2025 | SCHEDULE 13D/A | 0001193125-25-246866 |
| Oct 20, 2025 | 4 | 0001193125-25-243899 |
| Oct 17, 2025 | SCHEDULE 13D/A | 0001193125-25-242678 |
| Oct 17, 2025 | DEFR14A | 0001104659-25-100443 |
| Oct 17, 2025 | 8-K | 0001104659-25-100317 |